DK0728015T3 - Kombinatoriske polypeptidantigener - Google Patents

Kombinatoriske polypeptidantigener

Info

Publication number
DK0728015T3
DK0728015T3 DK93916641T DK93916641T DK0728015T3 DK 0728015 T3 DK0728015 T3 DK 0728015T3 DK 93916641 T DK93916641 T DK 93916641T DK 93916641 T DK93916641 T DK 93916641T DK 0728015 T3 DK0728015 T3 DK 0728015T3
Authority
DK
Denmark
Prior art keywords
polypeptide antigens
variants
combinatorial polypeptide
protein
antigens
Prior art date
Application number
DK93916641T
Other languages
Danish (da)
English (en)
Inventor
Roberto Crea
Original Assignee
Creagen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Creagen Inc filed Critical Creagen Inc
Application granted granted Critical
Publication of DK0728015T3 publication Critical patent/DK0728015T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • AIDS & HIV (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK93916641T 1992-06-18 1993-06-18 Kombinatoriske polypeptidantigener DK0728015T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US90012392A 1992-06-18 1992-06-18

Publications (1)

Publication Number Publication Date
DK0728015T3 true DK0728015T3 (da) 2006-07-17

Family

ID=25412008

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93916641T DK0728015T3 (da) 1992-06-18 1993-06-18 Kombinatoriske polypeptidantigener

Country Status (10)

Country Link
US (1) US6432675B1 (ja)
EP (1) EP0728015B1 (ja)
JP (2) JP3764476B2 (ja)
AT (1) ATE319738T1 (ja)
AU (1) AU678371B2 (ja)
DE (1) DE69333992T2 (ja)
DK (1) DK0728015T3 (ja)
ES (1) ES2260754T3 (ja)
PT (1) PT728015E (ja)
WO (1) WO1994000151A1 (ja)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7118874B2 (en) 1998-10-09 2006-10-10 Variation Biotechnologies Inc. Immunogenic formulation and process for preparation thereof
CA2472265C (en) * 2002-02-08 2013-02-05 Variation Biotechnologies Inc. Immunogenic formulations of variable peptidic epitopes and process for preparation thereof
AU2003228568A1 (en) * 2002-04-17 2003-11-03 Guido Cappuccilli "doping" in walk-through mutagenesis
RU2237065C2 (ru) * 2002-10-03 2004-09-27 Государственный научный центр вирусологии и биотехнологии "Вектор" Иммуногенная библиотека химерных пептидов, мимикрирующая генетическое многообразие гипервариабельного района v3 белка оболочки gp120 вируса иммунодефицита человека
WO2007030637A2 (en) * 2005-09-06 2007-03-15 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Hiv gp120 crystal structure and its use to identify immunogens
CA2627105A1 (en) * 2005-10-26 2007-05-03 Protelix, Inc. Influenza combinatorial antigen vaccine
EP1989326A4 (en) 2006-01-17 2009-09-30 Health Research Inc HETERO DUPLEX TRACKING TEST
JP5247009B2 (ja) * 2006-06-16 2013-07-24 独立行政法人理化学研究所 配列抽出装置、配列抽出方法、プログラムおよび記録媒体
BRPI0908625A2 (pt) * 2008-05-19 2019-09-24 Virginia Tech Intellectual Properties Inc método de inibir a entrada de uma proteína efetora patogênica em uma célula, método de identificar proteínas efetoras patogênicas, método para a leitura de compostos e método para prever se um gene em um genoma de um patógeno codifica ou não uma molécula efetora patogênica

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0255190A3 (en) 1986-08-01 1990-08-29 Repligen Corporation Recombinant polypeptides and their uses, inclusing assay for aids virus
EP0311228A3 (en) 1987-10-09 1990-05-02 Repligen Corporation Recombinant polypeptides and their uses, including assay for aids virus
US5010175A (en) * 1988-05-02 1991-04-23 The Regents Of The University Of California General method for producing and selecting peptides with specific properties
ATE151110T1 (de) 1988-09-02 1997-04-15 Protein Eng Corp Herstellung und auswahl von rekombinantproteinen mit verschiedenen bindestellen
JPH04502760A (ja) 1988-10-03 1992-05-21 レプリゲン・コーポレーション エイズの診断，予防および治療に有効な新規ｈｉｖ蛋白質およびペプチド
CA2058630A1 (en) 1989-06-05 1990-12-06 Charles F. Scott, Jr. Human monoclonal antibodies to hiv-1 mn gp 120
WO1991006575A1 (en) 1989-11-03 1991-05-16 Repligen Corporation Hiv-1 specific human monoclonal antibody
US5270170A (en) * 1991-10-16 1993-12-14 Affymax Technologies N.V. Peptide library and screening method

Also Published As

Publication number Publication date
AU4642893A (en) 1994-01-24
EP0728015A4 (en) 1997-01-29
AU678371B2 (en) 1997-05-29
ES2260754T3 (es) 2006-11-01
PT728015E (pt) 2006-07-31
US6432675B1 (en) 2002-08-13
ATE319738T1 (de) 2006-03-15
WO1994000151A1 (en) 1994-01-06
JP3764476B2 (ja) 2006-04-05
EP0728015A1 (en) 1996-08-28
EP0728015B1 (en) 2006-03-08
DE69333992D1 (de) 2006-05-04
DE69333992T2 (de) 2006-11-30
JPH07508520A (ja) 1995-09-21
JP2004121266A (ja) 2004-04-22

Similar Documents

Publication Publication Date Title
DK0817846T3 (da) Intracellulært domæne af HER-2/neu proteinet til forebyggelse eller behandling af maligniteter
DE69431805D1 (de) Struktur höherer ordnung und bindung von peptidnukleinsäuren
ATE303160T1 (de) Impfstoff gegen prostatakrebs
DK0527760T3 (da) Fremgangsmåder og præparater til vaccination mod HIV
NO862118L (no) Fremgangsmaate ved kvantitativ bestemmelse av protein c og aktivatorpreparat til gjennomfoering av fremgangsmaaten.
ATE101876T1 (de) Verfahren zur verringerung der heterogenitaet von monoklonalen antikoerpern.
DK0728015T3 (da) Kombinatoriske polypeptidantigener
ATE69108T1 (de) Elektrophoretisches gel hoher aufloesung sowie methode zur abscheidung von serumproteinen.
DK41590A (da) Forbedrede protein c-molekyler samt fremgangsmaade til fremstilling og aktivering af samme
DK0538341T3 (da) EHV-4-gycoproteinvaccine.
DE3787706D1 (de) Verfahren zur quantitativen Bestimmung der Antigene und Antikörper.
ES8606411A1 (es) Procedimiento para la determinacion de fibrina
FR2692282B1 (fr) Clonage du gene codant pour la proteine gp28.5 de t. gondii; fragments peptidiques issus de ladite proteine et leurs applications.
DK267287D0 (da) Fremgangsmaade til kontrol af en elektromotors standsning, samt organ til af udfoere denne fremgangsmaade
EP0218587A4 (en) MONOCLONAL ANTIBODIES AND IMMUNIZATION METHOD USING THE SAME.
ATE307201T1 (de) Srcr domäne-enthaltendes protein
KR890700355A (ko) 단백질-함유 항원의 부분양이온화와 면역화 및 탈감작법.
DK0476059T3 (da) Fremgangsmåder til forøgelse af modificeringshastigheden for metastabile bindinger
DE69000909D1 (de) Transportables brueckenteil zur ueberwindung von graeben.
DE58907208D1 (de) Verfahren zur Bestimmung von Antikörpern.
ATE62019T1 (de) Verfahren zur herstellung von hcmvglykoproteinen, antikoerper dagegen und hcmvvakzine und dazu zu verwendende rekombinante vektoren.
DE3873255D1 (de) Methoden und praeparate zur vorbeugung von ulcera.
ATE12986T1 (de) Verfahren zur bestimmung von carcinoembryonalem antigen (cea) und zur bestimmung geeignete antikoerperloesung.
DK0511516T3 (da) Schizosaccharomyces-specifikke polypeptider
ATE80554T1 (de) Verfahren zur passiven immunisierung von saeugetieren mittels gefluegel- und/oder rinderantik¯rper und zusammensetzungen zu diesem zweck.